ADVIL ALLERGY SINUS Drug Patent Profile
✉ Email this page to a colleague
When do Advil Allergy Sinus patents expire, and what generic alternatives are available?
Advil Allergy Sinus is a drug marketed by Haleon Us Holdings and is included in one NDA. There is one patent protecting this drug.
This drug has thirty-four patent family members in eighteen countries.
The generic ingredient in ADVIL ALLERGY SINUS is chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride profile page.
DrugPatentWatch® Generic Entry Outlook for Advil Allergy Sinus
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be February 28, 2027. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ADVIL ALLERGY SINUS?
- What are the global sales for ADVIL ALLERGY SINUS?
- What is Average Wholesale Price for ADVIL ALLERGY SINUS?
Summary for ADVIL ALLERGY SINUS
International Patents: | 34 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 3 |
Patent Applications: | 15 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in ADVIL ALLERGY SINUS? | ADVIL ALLERGY SINUS excipients list |
DailyMed Link: | ADVIL ALLERGY SINUS at DailyMed |
![ADVIL ALLERGY SINUS drug patent expirations Drug patent expirations by year for ADVIL ALLERGY SINUS](/p/graph/s/t/ADVIL_ALLERGY_SINUS-patent-expirations.png)
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for ADVIL ALLERGY SINUS
Generic Entry Date for ADVIL ALLERGY SINUS*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
TABLET;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for ADVIL ALLERGY SINUS
US Patents and Regulatory Information for ADVIL ALLERGY SINUS
ADVIL ALLERGY SINUS is protected by one US patents.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of ADVIL ALLERGY SINUS is ⤷ Sign Up.
This potential generic entry date is based on patent ⤷ Sign Up.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Patents protecting ADVIL ALLERGY SINUS
Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Haleon Us Holdings | ADVIL ALLERGY SINUS | chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride | TABLET;ORAL | 021441-001 | Dec 19, 2002 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ADVIL ALLERGY SINUS
See the table below for patents covering ADVIL ALLERGY SINUS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Peru | 20081072 | COMPOSICIONES DE ANTI-HISTAMINICOS, DESCONGESTIVOS, ANTITUSIVOS Y DROGAS ANTI-INFLAMATORIOS NO ESTEROIDALES | ⤷ Sign Up |
Spain | 2468217 | ⤷ Sign Up | |
Japan | 5241228 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |